Volume 82, Issue 5, Pages 598-604 (September 2012) Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation Jennifer M. DeVos, A. Osama Gaber, Richard J. Knight, Geoffrey A. Land, Wadi N. Suki, Lillian W. Gaber, Samir J. Patel Kidney International Volume 82, Issue 5, Pages 598-604 (September 2012) DOI: 10.1038/ki.2012.190 Copyright © 2012 International Society of Nephrology Terms and Conditions
Figure 1 Patient selection. DSA, donor-specific antibody. Kidney International 2012 82, 598-604DOI: (10.1038/ki.2012.190) Copyright © 2012 International Society of Nephrology Terms and Conditions
Figure 2 Time to DSA development post transplant. DSA, donor-specific antibody. Kidney International 2012 82, 598-604DOI: (10.1038/ki.2012.190) Copyright © 2012 International Society of Nephrology Terms and Conditions
Figure 3 Mean fluorescence index and outcomes. (a) Fluorescence index of DSA according to group. (b) Clinical outcomes based on MFI. DSA, donor-specific antibody; MFI, median fluorescence index. Kidney International 2012 82, 598-604DOI: (10.1038/ki.2012.190) Copyright © 2012 International Society of Nephrology Terms and Conditions